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Technologies for single-cell sequencing are improving
steadily. A recent study describes a new method for
interrogating all coding sequences of the human
genome at single-cell resolution.Such technologies may enable answering importantIntroduction
In a recent report in Genome Biology [1], Nick Navin
and colleagues develop a novel method for single-cell
sequencing, single-nucleus exome sequencing (SNES).
The method involves sorting single nuclei, a limited
amplification step, exome capture and sequencing. The
authors report good coverage across the exome and high
detection efficiencies for finding single-nucleotide va-
riants (SNVs) and small insertions and deletions (indels).
The SNES method exemplifies the current progress and
challenges in single-cell sequencing technologies [1].
Genomics studies have classically been performed on
populations of cells, obscuring variability within cell
populations. Mainly driven by the cancer field, sig-
nificant advances have been made in computational
methods that enable the characterization of different cell
populations from the sequences of DNA extracted from
a pool of many cells. However, accurate identification
and characterization of low-abundant populations of
cells requires bespoke experimental approaches. Over
the past few years, several groups have pioneered the
development of methods that allow profiling the DNA
of single cells for diverse types of genetic variation
(reviewed in [2]), and in fact in 2011 Navin et al. [3]
published the first method for high-resolution copy
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human cell without errors and find all kinds of genetic
variation is still to come, and will require major tech-
nical challenges to be overcome. The recent report in
Genome Biology [1] illustrates how single-cell sequencing
technologies are progressing in tackling those challenges.
questions in genetics, developmental biology and cancer
biology.
The challenges
A normal diploid cell contains about 6 pg of DNA, but
present-day sequencing technologies require hundreds
of nanograms of input material. To reach 500 ng of
DNA, the genomes of about 80,000 cells are needed, or
about 16 rounds of amplification from a single-cell genome.
Various whole-genome amplification (WGA) methods
have been developed and commercialized, each with spe-
cific advantages over the other, but no one method has
dominated for all purposes [4]. Multiple displacement
amplification (MDA) is a preferred method in the field for
attaining broad genome coverage and SNV detection.
However, all current WGA methods invariably cause arte-
facts: some loci or alleles are amplified more than others
and some may not amplify at all. Single-base errors are
made by the DNA polymerase despite its proof-reading
ability, and DNA chimeras are fabricated. Given that dif-
ferences between closely related cells can be very minor -
a normal cell division introduces roughly one single-base
change in a 6 Gb diploid genome - the errors produced
even by polymerases with low error rates, such as the
phi29 polymerase used in MDA, will quickly overwhelm
the real differences. A recent study estimated the per-
cycle per-base error rate for MDA to be about 3.2 × 10−6
[4], which would lead to about 19,000 false variants with
each round of amplification of a human diploid genome.
To somewhat temper the errors, Navin and colleagues
[1] first sorted and lysed single nuclei in a PCR tube, then
performed a time-limited MDA reaction and subsequentlyntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Voet and Van Loo Genome Biology  (2015) 16:86 Page 2 of 3selected, using a 22-chromosome quantitative PCR
panel, cells without locus drop out in their amplifica-
tion product, before conventional exome library prep-
aration and sequencing.
An important quality metric for SNV and indel detec-
tion following single-cell WGA sequencing is the breadth
of genome coverage (or in this case exome coverage),
defined as the percentage of nucleotides of the genome
(or exome) covered by at least one read. The authors [1]
demonstrate that SNES can capture 90% of the exome in
G0/1-phase cells and 96% in G2/M-phase cells - that is, in
cells before and after DNA replication, respectively. This
confirms that MDA can take a broad snapshot of the
genomic landscape of a cell, and additionally indicates that
having more DNA at the start of amplification has a posi-
tive effect. However, to call SNVs and indels at a particular
location, that locus of the reference genome has to be
layered with multiple sequencing reads of the cell. Using
SNES, 73% and 84% of the exome reached sufficient
coverage depth for genetic variant calling. These numbers
illustrate the current state-of-the-art in single-cell sequen-
cing: similar numbers were reported for other workflows
that used MDA before single-cell exome sequencing [5].
Other important metrics include false-discovery rates
and allele drop-out rates. Quantification of the number
of errors introduced following SNES revealed that 26
errors per Mb were introduced following WGA by MDA;
these were mostly false G:C > A:T transitions, although
false T:A > C:G transitions and C:G > A:T transversions
were also introduced [1,5]. Although this illustrates that
single-cell sequencing technologies still have a long way to
go, various groups have now observed that the large ma-
jority of errors of WGA occur at random sites and very
few are recurrently observed in multiple single cells. This
means that, in principle, variants observed in two (but
preferably more) cells can be reliably called genuine [1,5].
In contrast, allelic drop-outs of known heterozygous SNPs
amounted to 31% and 21% for G1/0- and G2/M-phase
nuclei, respectively, when only regions with sufficient
depth of coverage in the single cell were considered.
Importantly, in contrast to false-positive errors, allelic
dropouts can occur at recurrent positions in multiple
single cells [1], complicating the interpretation of loss-
of-heterozygosity events.
Single-cell genomics to dissect intra-tumor
heterogeneity
The emergence and evolution of cancer is driven by
somatic changes to the genome. To understand how
cancers develop and evolve, which cells enter the circu-
lation and metastasize, and ultimately how resistance to
treatment develops, we need to identify and study the
different cell populations that can occur within cancer,
and investigate how these populations are related. Althoughwe can infer a rough architecture of the tumor’s subclones
from sequencing bulk DNA of the tumor [6], the ultimate
resolution to study intra-tumor heterogeneity is at single-
cell level. Sequencing thousands or millions of individual
cancer cells of many different tumors would allow a
truly holistic view of tumor evolution, if the artefacts
and error rate can be mitigated. In addition, the costs of
such large-scale experiments are still prohibitive, mainly
because of the cost of sequencing itself, but also because
of the cost of amplification and library construction.
Navin and colleagues [1] report a total cost of approxi-
mately 30 US dollars per cell to generate single-cell libraries
(excluding exome capture). However, with cost-effective
sequencing platforms as the Illumina HiSeq X ten, whole-
genome sequencing of human single cells may now grad-
ually move to an affordable high-throughput scale that
will allow unique insights into cancer biology, and it may
soon outrun the use of single-cell exome sequencing.
Nevertheless, exome sequencing and, in particular,
cost-effective custom targeted resequencing protocols,
for example for cancer gene panels, will remain important
research tools for single-cell analyses.
One caveat of the present SNES method [1] in the
context of cancer genomics is the potential biases intro-
duced by the 22-chromosome quantitative PCR quality
control step. Because cancer cells may acquire copy
number alterations, this quality control will behave dif-
ferently for different subclonal populations. Such poten-
tial biases need to be kept in mind when designing an
experiment.
Exploring the role of somatic variation in other
diseases and normal development
Somatic mutations during development may be neutral,
contribute to the spectrum of normal phenotypic vari-
ation, or cause disease - not only cancer, but potentially
also various other diseases [7]. For instance, it is thought
that Joseph Merrick, an Englishman who lived in the late
19th century and whose life story was featured in the
play and movie ‘The Elephant Man’, had Proteus syn-
drome, which is caused by a somatic activating mutation
in the AKT1 gene, leading to overgrowth of skin, con-
nective and other tissues. Not only such very rare
diseases (less than one case per million), but also more
common diseases, including a variety of neurological
disorders, have been associated with somatic mutations
[7]. As occasional DNA alterations accumulate with each
cell cycle following conception, such new mutations are
inherited by descending daughter cells, and cell lineages
can thus be tracked, as was recently demonstrated for
the human brain using single-cell sequencing [8]. Som-
atic mutations may be prevalent throughout our body,
some confined to a single cell, others scattered across
ectoderm-, mesoderm- and endoderm-derived tissues,
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of normal developmental and disease processes, we ex-
pect that single-cell sequencing will have a transforma-
tive role. Error rates and artefacts still plague such
studies, although this study [1] represents one step along
the way to reduce those.
The future
Technologies in which sequencing reads can be traced
to the molecule of origin in the DNA sample have
demonstrated their usefulness for mitigating sequencing
error and artefacts for bulk DNA samples [9]. Similar
principles translated to single-cell or single-nucleus
sequencing technology may be able to further improve
the reliability of genetic variants called following inno-
vation in both experimental and computational tech-
niques. In addition, reducing reaction time of WGA
reactions and their reaction volumes to nanoliter scales
have demonstrated a positive effect on bias and artefacts,
and will lead to further advances.
Finally, methods for DNA and RNA sequencing of the
same single cell have emerged [10]. Such integrated ana-
lyses of the cell’s transcriptome and genome and even-
tually also its epigenome and proteome will enable a
more thorough understanding of the extent, function
and evolution of cellular heterogeneity in normal deve-
lopment and disease.
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